Cargando…
Using molecular similarity to highlight the challenges of routine immunoassay-based drug of abuse/toxicology screening in emergency medicine
BACKGROUND: Laboratory tests for routine drug of abuse and toxicology (DOA/Tox) screening, often used in emergency medicine, generally utilize antibody-based tests (immunoassays) to detect classes of drugs such as amphetamines, barbiturates, benzodiazepines, opiates, and tricyclic antidepressants, o...
Autores principales: | Krasowski, Matthew D, Pizon, Anthony F, Siam, Mohamed G, Giannoutsos, Spiros, Iyer, Manisha, Ekins, Sean |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688477/ https://www.ncbi.nlm.nih.gov/pubmed/19400959 http://dx.doi.org/10.1186/1471-227X-9-5 |
Ejemplares similares
-
Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction
por: Krasowski, Matthew D, et al.
Publicado: (2014) -
Using cheminformatics to predict cross reactivity of “designer drugs” to their currently available immunoassays
por: Krasowski, Matthew D, et al.
Publicado: (2014) -
Accidental intoxications in toddlers: lack of cross-reactivity of vilazodone and its urinary metabolite M17 with drug of abuse screening immunoassays
por: Martinez-Brokaw, Christina D., et al.
Publicado: (2019) -
Challenges Predicting Ligand-Receptor Interactions of Promiscuous Proteins: The Nuclear Receptor PXR
por: Ekins, Sean, et al.
Publicado: (2009) -
Computational toxicology: risk assessment for chemicals
por: Ekins, Sean
Publicado: (2018)